OXY(US:OXY) Zheng Quan Shi Bao Wang·2025-10-02 01:13Core Viewpoint - Warren Buffett's Berkshire Hathaway is reportedly close to acquiring Occidental Petroleum's chemical subsidiary OxyChem for approximately $10 billion, marking the largest acquisition since 2022 [1][2]. Group 1: Acquisition Details - The acquisition of OxyChem, if finalized, will be Berkshire Hathaway's largest deal since the $13.7 billion purchase of Alleghany Corp in 2022 [2]. - Occidental Petroleum has been divesting assets to reduce debt, with the sale of OxyChem seen as a significant step in this process [2][3]. - OxyChem generated revenues of $2.42 billion in the first two quarters of this year [4]. Group 2: Financial Context - As of June 30, Berkshire Hathaway's cash reserves exceeded $340 billion, providing ample liquidity for the acquisition [5][6]. - In Q2 2023, Berkshire reported revenues of $92.515 billion, a slight decrease from $93.653 billion in the same period last year, with a net profit of $12.37 billion, down 59% year-over-year [5]. - The company has been selling stocks for 11 consecutive quarters, with a net sale of approximately $3 billion in Q2 2023 [5]. Group 3: Occidental Petroleum's Financial Situation - Occidental Petroleum's debt burden stood at $23.34 billion as of June 30, following a $10.8 billion acquisition of CrownRock LP in 2023 [3]. - The company has sold nearly $4 billion in assets since last year to manage its debt, which stems from a $55 billion acquisition of Anadarko Petroleum in 2019 [3].